FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/12/2026
TG Therapeutics, Inc. (NASDAQ: TGTX) reported Q4 EPS of ($0.19), $0.01 worse than the analyst estimate of ($0.18). Revenue for the quarter came in at $38.1 million versus the consensus estimate of $40 million.
For earnings history and earnings-related data on TG Therapeutics, Inc. (TGTX) click here.... More

